Completed NA INTERVENTIONAL 2-arm NCT02234479

MediHoney for Radiation Dermatitis

A Pilot Study: Topical Application of Medihoney for Management of Radiation Dermatitis

Sponsor: Integra LifeSciences Corporation

Conditions Breast Cancer Radiation Dermatitis

Interventions Hydrophor (Group A) MediHoney (Group B)

Updated 8 times since 2017 Last updated: Mar 16, 2020 Started: Jun 30, 2014 Primary completion: Nov 30, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer and Radiation Dermatitis, this trial is completed. The trial is conducted by Integra LifeSciences Corporation and has accumulated 8 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA
Sep 2019 — Apr 2020 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Sep 2019 [monthly]

Completed NA
Feb 2018 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2018 [monthly]

Completed NA

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Integra LifeSciences Corporation
University of Maryland, Baltimore

Data source: University of Maryland, Baltimore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States